Trials / Conditions / Tumor-induced Osteomalacia (TIO)
Tumor-induced Osteomalacia (TIO)
3 registered clinical trials studyying Tumor-induced Osteomalacia (TIO).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO NCT05357573 | Kyowa Kirin Co., Ltd. | Phase 4 |
| Active Not Recruiting | Tumor-induced Osteomalacia Disease Monitoring Program NCT04783428 | Ultragenyx Pharmaceutical Inc | — |
| Completed | Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS) NCT02304367 | Kyowa Kirin, Inc. | Phase 2 |